login
login

Europe Daily Bulletin No. 12829

10 November 2021
Contents Publication in full By article 23 / 34
EU RESPONSE TO COVID-19 / Health
EMA to provide EU27 with recommendations on possible emergency use of molnupiravir for Covid-19

09/11/2021 (Agence Europe)The European Medicines Agency (EMA) announced on Monday 8 November that it would provide additional guidance to Member States' health authorities on the oral antiviral drug molnupiravir (see EUROPE B12819A21), with a view to authorising the use of this possible Covid-19 treatment for emergency situations. Molnupiravir, developed by Merck, was approved last week in the UK, but is still awaiting market authorisation in Europe. The EMA is continuing to work on...

Contents

ECONOMY - FINANCE - BUSINESS
SECTORAL POLICIES
EXTERNAL ACTION
EU RESPONSE TO COVID-19
COURT OF JUSTICE OF THE EU
NEWS BRIEFS
CORRIGENDUM